RC5-86702-53549
2 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 926 / CA
- Registered
- 2022-07-10
- Relationship
- Child or adolescent in my care
- Guardian
- YE4-28769-54078
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-08
Dose 1 — Moderna
-
2022-07-10
Registered in v-safe
- 2022-07-11
- 2022-07-12
- 2022-07-13
- 2022-07-14
- 2022-07-15
- 2022-07-22
- 2022-07-31
-
2022-08-05
Dose 2 — Moderna
- 2022-08-09
- 2022-08-10
- 2022-08-11
- 2022-08-12
- 2022-08-19
- 2022-08-26
-
2022-09-02
Survey response — day 28, dose 2, under 3MedDRA: Adverse reaction, Dysphonia, Nasal congestion, Sneezing — Feeling: GoodFree text: Allergy type symptoms; sneezing, nasal congestion, hoarse voiceMedDRA releases: 2024-11 · check-in free text available
- 2022-09-09
- 2022-09-18
- 2022-11-05
- 2023-02-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-08 | Moderna | No |
| 2 | 2022-08-05 | Moderna | No |
Free text
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Allergy type symptoms; sneezing, nasal congestion, hoarse voice
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Adverse reaction | · | · | ✓ |
| SD | Dysphonia | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release